ReviewClinical and experimental gastroenterology2017
Duodenal and jejunal Dieulafoy's lesions: optimal management.
Review in Clinical and experimental gastroenterology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed, 1 synthesis or guideline pooled it, 31 citations in OpenAlex.
- Jejunal Dieulafoy's Lesion: A Systematic Review of Evaluation, Diagnosis, and Management.Journal of investigative medicine high impact case reportsPooled it
- Article
- [Rare massive upper gastrointestinal bleeding: Three cases of DieulafoyZhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences · 2025Review
- Bleeding Duodenal Dieulafoy's Lesion in a Pediatric Patient From Ethiopia: A Case Report.Clinical case reports · 2025Article
- Article
- Article
- A diagnostic dilemma: a case report of concomitant duodenal Dieulafoy lesion and gastric ulcer.Journal of surgical case reports · 2024Article
- Article
- Upper gastrointestinal bleeding due to Dieulafoy's lesion of the stomach: a rare case report.EXCLI journal · 2023Article
- A Challenging Case of Jejunal Dieulafoy's Lesion: A Rare Cause of Refractory Lower-Gastrointestinal Bleeding.The American journal of case reports · 2022Article
- Therapeutic endoscopy of a Dieulafoy lesion in a 10-year-old girl: A case report.World journal of clinical cases · 2022Article
- A rare case of Goodpasture syndrome concomitant with bleeding jejunal Dieulafoy's lesion.Clinical journal of gastroenterology · 2020Article
- Massive Gastrointestinal Bleeding From a Jejunal Dieulafoy's Lesion.ACG case reports journal · 2020Article
- Dieulafoy lesion: two pediatric case reports.Italian journal of pediatrics · 2020Article
- Article
- Dieulafoy's lesion of the duodenum: a comparative review of 37 cases.BMJ case reports · 2018Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Dieulafoy's lesions (DLs) are rare and cause gastrointestinal bleeding resulting from erosion of dilated submucosal vessels. The most common location for DL is the stomach, followed by duodenum. There is little information about duodenal and jejunal DLs. Challenges for diagnosis and treatment of Dieulafoy's lesions include the rare nature of the disease, asymptomatic patients, bleeding symptoms often requiring rapid diagnosis and treatment in symptomatic patients, variability in the diagnosis and treatment methods resulting from different lesion locations, and the risk of re-bleeding. For these reasons, there is no universal consensus about the diagnosis and treatment approach. There are few published case reports and case series recently published. Most duodenal DLs are not evaluated seperately in the studies, which makes it difficult to determine the optimal model. In this study, we summarize the general aspects and recent approaches used to treat duodenal DL.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.